| For: | Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol 2021; 27(24): 3609-3629 [PMID: 34239273 DOI: 10.3748/wjg.v27.i24.3609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3609.htm |
| Number | Citing Articles |
| 1 |
Anuradha Tyagi, Vinay Kumar. The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health. World Journal of Microbiology and Biotechnology 2025; 41(7) doi: 10.1007/s11274-025-04395-7
|
| 2 |
Feixiang Xiong, Xuejie Zhang, Yuyong Jiang, Peipei Meng, Yang Zhou, Xiaomin Ji, Jialiang Chen, Tong Wu, Yixin Hou. An Integrated Analysis of the Role of Gut Microbiome-Associated Metabolites in the Detection of MASH-Related Cirrhosis. Metabolites 2024; 14(12) doi: 10.3390/metabo14120681
|
| 3 |
Luran Yang, Mei Hua, Da Li, Fan Li, Yuguang He, Xinyu Miao, Mubai Sun, Honghong Niu, Fenghao An, Jing Wang, Min Yang, Jinyuan Lu, Hongyan Xu, Jinghui Wang. Protective Effects of Ginseng Soluble Dietary Fiber and Its Fecal Microbiota Extract on Antibiotic-Induced Gut Dysbiosis Obese Mice. Journal of Microbiology and Biotechnology 2025; 35 doi: 10.4014/jmb.2502.02013
|
| 4 |
Caiguang Liu, Shukai Zhan, Na Li, Tong Tu, Jianming Lin, Manying Li, Minhu Chen, Zhirong Zeng, Xiaojun Zhuang. Bile acid alterations associated with indolent course of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2023; 58(9) doi: 10.1080/00365521.2023.2200518
|
| 5 |
XuWen Zheng, JinNuo Fan, JinNan Yin, Ying Chu. The role of gut microbiota and plasma metabolites in ulcerative colitis: Insights from Mendelian randomization analysis. Medicine 2025; 104(9) doi: 10.1097/MD.0000000000041710
|
| 6 |
Na Li, Cheng Zhao, Pingnan Zhang, Songting Wu, Xiaotan Dou, Saifei Xu, Xiaoqi Zhang, Chunyan Peng, Ying Xie, Shuling Huang, Lin Zhou, Yonghua Shen, Lei Wang, Jinglin Wang, Chenggong Yu. The role of gut microbiota associated metabolites in digestive disorders. Engineered Regeneration 2024; 5(2) doi: 10.1016/j.engreg.2024.04.003
|
| 7 |
Miranda Green, Jane A. Foster. Microbes, Microbial Metabolism, and Mucosal Immunity. 2024; doi: 10.1016/B978-0-323-90144-4.00002-1
|
| 8 |
Pengkui Xia, Tao Hou, Hong Jin, Yaqi Meng, Jing Li, Fuchao Zhan, Fang Geng, Bin Li. A critical review on inflammatory bowel diseases risk factors, dietary nutrients regulation and protective pathways based on gut microbiota during recent 5 years. Critical Reviews in Food Science and Nutrition 2024; 64(24) doi: 10.1080/10408398.2023.2204147
|
| 9 |
Shanshan Zhong, Fangxi Liu, Rashid Giniatullin, Jukka Jolkkonen, Yong Li, Zhike Zhou, Xinyu Lin, Chang Liu, Xiuchun Zhang, Zhouyang Liu, Cheng Lv, Qianqian Guo, Chuansheng Zhao. Blockade of CCR5 suppresses paclitaxel-induced peripheral neuropathic pain caused by increased deoxycholic acid. Cell Reports 2023; 42(11) doi: 10.1016/j.celrep.2023.113386
|
| 10 |
Kan Gao, Pu Xiu Wang, Xue Mei, Tao Yang, Kai Yu. Untapped potential of gut microbiome for hypertension management. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2356278
|
| 11 |
Jiahui Zheng, Huan Li, Pei Zhang, Shijun Yue, Bingtao Zhai, Junbo Zou, Jiangxue Cheng, Chongbo Zhao, Dongyan Guo, Jing Wang. Paeonol Ameliorates Ulcerative Colitis in Mice by Modulating the Gut Microbiota and Metabolites. Metabolites 2022; 12(10) doi: 10.3390/metabo12100956
|
| 12 |
Yousi Fu, Douglas V. Guzior, Maxwell Okros, Christopher Bridges, Sabrina L. Rosset, Cely T. González, Christian Martin, Hansani Karunarathne, Victoria E. Watson, Robert A. Quinn. Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammation. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-58649-x
|
| 13 |
Jose Haro-Reyes, Jayaprakash Kanijam Raghupathi, Lavanya Reddivari. Composition of Human-Associated Gut Microbiota Determines 3-DF and 3-HF Anti-Colitic Activity in IL-10 -/- Mice. Nutrients 2024; 16(23) doi: 10.3390/nu16234232
|
| 14 |
Fangjia Hao, Jiamin ZHU, Ning Zhang, Peng He, Qiandan Miao, Yumin Liu, Yu Gao, Xijian Liu, Guoying Deng, Zhong Zhang, Meiqing Feng, Linjing Zhao. Association between Gut Microbiome and Metabolome in Mice Suffering from Acute Carbapenem-Resistant <i>Escherichia coli</i> Infection. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3906496
|
| 15 |
Jinlan Zhang, Shuhui Sun, Huan Chen, Yifan Feng, Ying Li, Zhengqi Dong. Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1197144
|
| 16 |
Andy Acevedo-Román, Natalia Pagán-Zayas, Liz I. Velázquez-Rivera, Aryanne C. Torres-Ventura, Filipa Godoy-Vitorino. Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179715
|
| 17 |
Yiwen Li, Haocun Kong, Caiming Li, Zhengbiao Gu, Xiaofeng Ban, Zhaofeng Li. Specific Formulation of Xylo-Oligosaccharides and Isomalto-Oligosaccharides Alleviates Metabolic Disturbance and Intestinal Barrier Dysfunction Induced by High-Fat Diet. Journal of Agricultural and Food Chemistry 2025; 73(52) doi: 10.1021/acs.jafc.5c07137
|
| 18 |
Jie Fang, Chen-Huan Yu, Xue-Jian Li, Jin-Mei Yao, Zheng-Yu Fang, Soo-Hyun Yoon, Wen-Ying Yu. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.997018
|
| 19 |
Ludong Tan, Feng Jia, Yahui Liu. Advances in research on the role of gut microbiota in the pathogenesis and precision management of gallstone disease. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1535355
|
| 20 |
Bianca Bartocci, Angelo Del Gaudio, Marco Murgiano, Alfredo Papa, Giovanni Cammarota, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso. Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD. Microorganisms 2026; 14(5) doi: 10.3390/microorganisms14051082
|
| 21 |
Samantha H. Bai, Arun Chandnani, Siyan Cao. Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment. Biomedicines 2024; 12(12) doi: 10.3390/biomedicines12122910
|
| 22 |
Dengli Wu, Hongmei Wu, Piao Yu, Hongyun Liu, Mei Liu, Junyi Wang, Xiangpei Wang, Feng Xu. Unraveling the molecular mechanism of aqueous extract of Sargentodoxa cuneata against ulcerative colitis from serum metabolomics and bioinformatics perspectives. Journal of Chromatography B 2024; 1249 doi: 10.1016/j.jchromb.2024.124372
|
| 23 |
Morgane M. Thibaut, Laure B. Bindels. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation. Trends in Molecular Medicine 2022; 28(3) doi: 10.1016/j.molmed.2021.12.006
|
| 24 |
Na Li, Peiguang Ma, Yalan Li, Xuekai Shang, Xinmei Nan, Lei Shi, Xiao Han, Jiajing Liu, Yanfei Hong, Qiuyi Li, Jiaqi Cui, Junxiang Li, Guiying Peng. Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2290315
|
| 25 |
Lie Zheng. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(30): 10823-10839 doi: 10.12998/wjcc.v10.i30.10823
|
| 26 |
Yue Zhang, Yue Fang, Yan Chen, Quan Chen, Wenwen Liu, Min Xu, Lihua Xing, Rulin Wang, Lei Wang, Nianjun Yu, Daiyin Peng, Yanyan Wang, Weidong Chen. Poria cocos polysaccharides as a carbon source promotes the proliferation of Parabacteroides distasonis to ameliorate ulcerative colitis: A mechanistic study based on the secondary bile acid-TGR5 axis. International Journal of Biological Macromolecules 2025; 331 doi: 10.1016/j.ijbiomac.2025.148476
|
| 27 |
Siying Li, Yanmin He, Weike Shaoyong, Yizhen Wang, Mingliang Jin. Integrating bile acid metabolism into precision nutrition strategies for improved swine performance. Animal Nutrition 2026; 24 doi: 10.1016/j.aninu.2025.05.013
|
| 28 |
Shiwen Hua, Xiang Li, Zhenli Xu, Rui Chen, Qinghua Wu, Wenge Yang, Yun Tao, Shanshan Duan, Jian Ding, Jie Wan, Jingjie Lei, Yang Cheng, Yifan Sun, Youyi Liu, Su Han. Bile acid alterations in biliary obstruction patients with clonorchiasis. Acta Tropica 2026; 274 doi: 10.1016/j.actatropica.2026.107989
|
| 29 |
Bingjie Xiang, Jun Hu, Min Zhang, Min Zhi. The involvement of oral bacteria in inflammatory bowel disease. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae076
|
| 30 |
Brown fermented milk alleviates diarrhea via unique metabolomic mechanisms. npj Science of Food 2025; 9(1) doi: 10.1038/s41538-025-00563-z
|
| 31 |
Dickson Kofi Wiredu Ocansey, Sanhua Hang, Xinyi Yuan, Hua Qian, Mengjiao Zhou, Chinasa Valerie Olovo, Xu Zhang, Fei Mao. The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2176118
|
| 32 |
Yueyue Ma, Haoze Yang, Xiaoming Wang, Yuhong Huang, Yuhong Li, Guixiang Pan. Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies. Journal of Ethnopharmacology 2025; 337 doi: 10.1016/j.jep.2024.118968
|
| 33 |
Jing Li, Ai-hua Zhang, Fang-fang Wu, Xi-jun Wang. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841552
|
| 34 |
Junyan Cao, Yanchun Chang, Yonghui Li, Hailong Li, Yinfeng Tan. Development of a UPLC-MS/MS method for simultaneous quantification of 7 bile acids in feces: application to UC mice. Bioanalysis 2025; 17(19) doi: 10.1080/17576180.2025.2571025
|
| 35 |
Maria Rynikova, Viktoria Bojcukova, Vlasta Demeckova. One therapy, many targets: redefining ulcerative colitis treatment through fecal microbiota transplantation. Therapeutic Advances in Gastroenterology 2026; 19 doi: 10.1177/17562848261437918
|
| 36 |
Guanzhou Zhou, Nana Zhang, Ke Meng, Fei Pan. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1001623
|
| 37 |
Zhenhua Liu, Chongge You. The bile acid profile. Clinica Chimica Acta 2025; 565 doi: 10.1016/j.cca.2024.120004
|
| 38 |
Simei Yue, Yulin Tan, Lingjiao Gong, Fei Liao. Role and progression of bile acid metabolism in mediating Th17/Treg homeostasis in inflammatory bowel disease. iScience 2026; 29(3) doi: 10.1016/j.isci.2026.114961
|
| 39 |
Dan Liu, Ran Zhao, Yajing Wu, Yunhong Wang, Rongping Yang, Xiumei Ke. Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.819851
|
| 40 |
Eszter Pal, Neda Omidi Arjenaki, Yao Lu, Jianguo Xia, Lorraine Chalifour. Acute myocardial infarction induces sex-specific, time-dependent remodeling of the gut microbiome and intestinal immune compartment in retired breeder C57BL/6N mice. Frontiers in Microbiomes 2026; 5 doi: 10.3389/frmbi.2026.1818652
|
| 41 |
Fangfei Xiao, Fang Dong, Xiaolu Li, Youran Li, Guangjun Yu, Zhanju Liu, Yizhong Wang, Ting Zhang. Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.902337
|
| 42 |
Zelin Guan, Peilin Niu, Qichao Tan, Yidong Wang, Shujing Deng, Danyang Wang, Kai Dong, Jianfeng Xing, Cuiyu You. Therapeutic systems based on natural gut microbiota modulators: the latest advances in the treatment of inflammatory bowel disease. Materials Advances 2025; 6(5) doi: 10.1039/D4MA00896K
|
| 43 |
Xiaoxin Jiang, Jingyi Ren, Gejun Yu, Wentao Wu, Mengyuan Chen, Yun Zhao, Canxia He. Targeting Bile-Acid Metabolism: Nutritional and Microbial Approaches to Alleviate Ulcerative Colitis. Nutrients 2025; 17(7) doi: 10.3390/nu17071174
|
| 44 |
Hitomi Kubota, Michiyasu Ishizawa, Makoto Kodama, Yoshihiro Nagase, Shigeaki Kato, Makoto Makishima, Kenichi Sakurai. Vitamin D Receptor Mediates Attenuating Effect of Lithocholic Acid on Dextran Sulfate Sodium Induced Colitis in Mice. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043517
|
| 45 |
Youping Liu, Meng Yang, Zhiling Ran, Junxia Wang, Wujie Ma, Qiaoni Sheng. Effect of Different Doses of Vitamin D on the Intestinal Flora of Babies with Eczema: An Experimental Study. Life 2022; 12(9) doi: 10.3390/life12091409
|
| 46 |
Gabrio Bassotti, Alessandro Fruganti, Fabrizio Stracci, Pierfrancesco Marconi, Katia Fettucciari. Cytotoxic synergism of <i>Clostridioides difficile</i> toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases. World Journal of Gastroenterology 2023; 29(4): 582-596 doi: 10.3748/wjg.v29.i4.582
|
| 47 |
Tim Kaden, Manuel Allwang, Johannes Stallhofer, Katja Graf, Martin Raasch, Alexander S. Mosig. Secondary bile acid lithocholic acid ameliorates colitis-like inflammation in a human intestine-on-chip system. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1761539
|
| 48 |
Yunlong Dong, Hongjie Song, Andrew J. Holmes, Jiabao Yan, Cuiru Ren, Ying Zhang, Wei Zhao, Jianhui Yuan, Yuyang Cheng, David Raubenheimer, Zhenwei Cui. Normal diet ameliorates obesity more safely and effectively than ketogenic diet does in high-fat diet-induced obesity mouse based on gut microbiota and lipid metabolism. International Journal of Food Sciences and Nutrition 2023; 74(5) doi: 10.1080/09637486.2023.2235899
|
| 49 |
Hao Cheng, Juan Liu, Dandan Zhang, Jing Wang, Yuzhu Tan, Wuwen Feng, Cheng Peng. Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.817600
|
| 50 |
Ipsita Mohanty, Helena Mannochio-Russo, Joshua V. Schweer, Yasin El Abiead, Wout Bittremieux, Shipei Xing, Robin Schmid, Simone Zuffa, Felipe Vasquez, Valentina B. Muti, Jasmine Zemlin, Omar E. Tovar-Herrera, Sarah Moraïs, Dhimant Desai, Shantu Amin, Imhoi Koo, Christoph W. Turck, Itzhak Mizrahi, Penny M. Kris-Etherton, Kristina S. Petersen, Jennifer A. Fleming, Tao Huan, Andrew D. Patterson, Dionicio Siegel, Lee R. Hagey, Mingxun Wang, Allegra T. Aron, Pieter C. Dorrestein. The underappreciated diversity of bile acid modifications. Cell 2024; 187(7) doi: 10.1016/j.cell.2024.02.019
|
| 51 |
Donglin Yu, Shiqin Xie, Mingmin Guo, Yi Wu, Qianghong Tian, Zhiyan Wang, Sainan Zhou, Ying Cai. External damp environment aggravates diarrhea in spleen deficiency and dampness syndrome in mice: involvement of small intestinal contents microbiota, energy metabolism, gastrointestinal and fluid functions. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1495311
|
| 52 |
Jing Wang, Mei He, Ming Yang, Xiaopeng Ai. Gut microbiota as a key regulator of intestinal mucosal immunity. Life Sciences 2024; 345 doi: 10.1016/j.lfs.2024.122612
|
| 53 |
Dinesh Mohan Swamikkannu, Santhosha Dasarapu, Rajendra Prasad Velivela Siva, Javali Nallam, Satvika Pabba. The gut-liver nexus: exploring gut microbiota dysbiosis in non-alcoholic fatty liver disease and its therapeutic implications. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00331-w
|
| 54 |
Xiong-Quan Long, Ming-Zhu Liu, Zi-Hao Liu, Lv-Zhou Xia, Shi-Peng Lu, Xiao-Ping Xu, Ming-Hao Wu. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease. World Journal of Gastroenterology 2023; 29(27): 4252-4270 doi: 10.3748/wjg.v29.i27.4252
Abstract(1092) |
Core Tip(1031) |
Full Article(HTML)(6529)
|
Full Article (PDF)-4399K(507)
|
Full Article with Cover (PDF)-5511K(673)
|
Full Article (Word)-1914K(89)
|
Full Article (XML)-388K(193)
|
Audio-589K(10)
|
Peer-Review Report-261K(185)
|
Answering Reviewers-93K(190)
|
Times Cited (24)
|
Total Visits (9706)
|
Open
|
| 55 |
Haoran Shen, Xiaoyou Yu, Zhiyu Wang, Sitong Zhou, Jiandong Jiang, Huihui Guo, Yanxing Han. Gut Microbiota Remodeling Mediates the Therapeutic Effects of a Plant-Based Medicine on DSS-Induced Ulcerative Colitis in Mice via the Butyrate-SVCT1-Vitamin C Axis. International Journal of Molecular Sciences 2026; 27(5) doi: 10.3390/ijms27052245
|
| 56 |
Robert Battat, Soumya Kandi, Ana P Lacerda, Phil Levine, Ezequiel Neimark, Brian G Feagan, David T Rubin, Qin C Ji, Xin Chen, Sarah Blink Polakow. Association of bile acid diarrhea with symptoms and disease activity in Crohn’s disease: post-hoc clinical trial analysis of serum 7a-hydroxy-4cholestern-3-one, C4, in patients with active Crohn’s disease. Journal of Crohn's and Colitis 2025; 19(5) doi: 10.1093/ecco-jcc/jjaf053
|
| 57 |
Yayun Xu, Hui Jing, Jianfa Wang, Shilong Zhang, Qimeng Chang, Zhanming Li, Xubo Wu, Ziping Zhang. Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.800604
|
| 58 |
Dong-xuan Zheng, Yu Wang, Qiang Hou, Li-mei Wen, Jiang-yun Liu, Qiang Yin, Hai-long Yin, Zao-ling Liu, Jun-ping Hu, Jian-hua Yang. Yanxiao Di’naer decoction attenuates metabolic dysfunction-associated steatohepatitis through the regulation of gut microbiota and the metabolism of bile acid. Journal of Ethnopharmacology 2026; 364 doi: 10.1016/j.jep.2026.121486
|
| 59 |
Hang Si, Yuan Gao, Hairihan Li, Xin Li, Qiuwen He, Jun Wang, Na Chen, Qinggele Borjihan, Yongfu Chen. Bifidobacterium animalis ssp. lactis BX-245-fermented milk alleviates inflammatory bowel disease by modulating the gut microbiota and metabolite profile. Journal of Dairy Science 2026; 109(6) doi: 10.3168/jds.2025-28051
|
| 60 |
Sithara Vivek, You Shan Shen, Weihua Guan, Guillaume Onyeaghala, Mosunmoluwa Oyenuga, Christopher Staley, Amy B. Karger, Anna E. Prizment, Bharat Thyagarajan. Association between Circulating T Cells and the Gut Microbiome in Healthy Individuals: Findings from a Pilot Study. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25136831
|
| 61 |
Hiromi Suzuki, Mitsuyoshi Suzuki, Keisuke Jimbo, Musashi Hibio, Takahiro Sasaki, Tsuyoshi Murai, Yukiko Yamashita, Mizuho Une, Shojiro Ogawa, Toru Okamoto, Seiko Narushima, Wataru Suda, Genta Kakiyama, Taka-aki Matsuyama, Hajime Takei, Hiroshi Nittono. Fecal fatty acid-linked bile acid profiles in pediatric patients with ulcerative colitis. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120060
|
| 62 |
Xiaoyu Cai, Zhi Li, Yao Yao, Yongquan Zheng, Meng Zhang, Yiqing Ye. Glycolithocholic acid increases the frequency of circulating Tregs through constitutive androstane receptor to alleviate postmenopausal osteoporosis. Biochemical Pharmacology 2024; 219 doi: 10.1016/j.bcp.2023.115951
|
| 63 |
Tadakuni Monma, Junichi Iwamoto, Hajime Ueda, Makoto Tamamushi, Fumio Kakizaki, Naoki Konishi, Shoichiro Yara, Teruo Miyazaki, Takeshi Hirayama, Tadashi Ikegami, Akira Honda. Evaluation of gut dysbiosis using serum and fecal bile acid profiles. World Journal of Clinical Cases 2022; 10(34): 12484-12493 doi: 10.12998/wjcc.v10.i34.12484
|
| 64 |
Ana Paula V. Colombo, Adriana M. de Oliveira, Nobuhiko Kamada, Sho Kitamoto. Periodontitis and Inflammatory Bowel Diseases: Mechanistic Evidence. Journal of Periodontal Research 2026; doi: 10.1111/jre.70124
|
| 65 |
Fan Jingjing, Jin Weilin, Su Shaochen, Khan Aman, Wu Ying, Chen Yanyi, Feng Pengya, Jeon Byong‐Hun, Salama EL‐Sayed, Ling Zhenmin, Liu Pu, Li Xiangkai. A Probiotic Targets Bile Acids Metabolism to Alleviate Ulcerative Colitis by Reducing Conjugated Bile Acids. Molecular Nutrition & Food Research 2024; 68(7) doi: 10.1002/mnfr.202300731
|
| 66 |
Lanlan Yi, Guangyao Song, Xuancheng Guan, Huijin Jia, Wenjie Cheng, Yuxiao Xie, Yanguang Zhao, Junhong Zhu, Sumei Zhao. Taurocholate mitigates LPS-induced intestinal barrier injury via host–microbiota and inflammatory pathway regulation. Ecotoxicology and Environmental Safety 2026; 311 doi: 10.1016/j.ecoenv.2026.119897
|
| 67 |
Fangjia Hao, Jiamin Zhu, Ning Zhang, Peng He, Qiandan Miao, Yumin Liu, Yu Gao, Xijian Liu, Guoying Deng, Zhong Zhang, Meiqing Feng, Linjing Zhao. Association between gut microbiome and metabolome in mice suffering from acute carbapenem-resistant Escherichia coli infection. Journal of Pharmaceutical and Biomedical Analysis 2022; 215 doi: 10.1016/j.jpba.2022.114770
|
| 68 |
Yue Liu, Ping Ren, Hailong Li, Yingying Liu, Yiting Yang, Wanting Wang, Jiaming Zhou, Ling Su, Lili Guan, Hongxia Ma.
Nostoc commune Vauch. polysaccharide alleviates Pb-induced hepatorenal toxicity by changing gut bacteriome, mycobiome, and metabolome
. Food Science and Human Wellness 2024; 13(6) doi: 10.26599/FSHW.2023.9250032
|
| 69 |
Lin Yuan, Ying Li, Moutong Chen, Liang Xue, Juan Wang, Yu Ding, Qihui Gu, Jumei Zhang, Hui Zhao, Xinqiang Xie, Qingping Wu. Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives. Applied Microbiology and Biotechnology 2024; 108(1) doi: 10.1007/s00253-024-13007-7
|
| 70 |
Yonghoon Choi, Soo In Choi, Nayoung Kim, Ryoung Hee Nam, Jae Young Jang, Hee Young Na, Cheol Min Shin, Dong Ho Lee, Huitae Min, Yeon-Ran Kim, Yeong-Jae Seok. Effect of Clostridium butyricum on High-Fat Diet-Induced Intestinal Inflammation and Production of Short-Chain Fatty Acids. Digestive Diseases and Sciences 2023; 68(6) doi: 10.1007/s10620-023-07835-2
|
| 71 |
Marco Losa, Marlene Schwarzfischer, Marc Emmenegger, Marianne R. Spalinger, Gerhard Rogler, Michael Scharl. Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26168042
|
| 72 |
Jiachun Ni, Yuchang Lu, Jiaying Tan, Jiaqi Jiang, Yunyun Wang, Dan Gan, Can Cui, Jiong Wu, Haojie Yang, Zhenyi Wang. QuYuShengXin formula reshapes bile-acid-mediated macrophage polarization in the treatment of ulcerative colitis. BMC Complementary Medicine and Therapies 2025; 26(1) doi: 10.1186/s12906-025-05177-2
|
| 73 |
Seyedeh Maryam Mousavi, Mohammad Roayaei Ardakani, Hamid Galehdari, Mehran Dorostghoal. Integrated multi-omics profiling of gut microbiome and metabolome in ulcerative colitis insights from the Iranian population. iScience 2026; 29(3) doi: 10.1016/j.isci.2026.114721
|
| 74 |
Stefanie Sommersberger, Stefan Gunawan, Tanja Elger, Tanja Fererberger, Johanna Loibl, Muriel Huss, Arne Kandulski, Sabrina Krautbauer, Martina Müller, Gerhard Liebisch, Christa Buechler, Hauke Christian Tews. Altered fecal bile acid composition in active ulcerative colitis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01971-4
|
| 75 |
Jingjing Fan, Ying Wu, Xing Wang, Habib Ullah, Zhenmin Ling, Pu Liu, Yu Wang, Pengya Feng, Jing Ji, Xiangkai Li. The probiotic enhances donor microbiota stability and improves the efficacy of fecal microbiota transplantation for treating colitis. Journal of Advanced Research 2026; 79 doi: 10.1016/j.jare.2025.03.017
|
| 76 |
Sho Kitamoto, Nobuhiko Kamada. The oral-gut axis: a missing piece in the IBD puzzle. Inflammation and Regeneration 2023; 43(1) doi: 10.1186/s41232-023-00304-3
|
| 77 |
Tianyu Yu, Jun Yan, Ruochen Wang, Lei Zhang, Xiake Hu, Jiaxi Xu, Fanni Li, Qi Sun. Integrative Multiomics Profiling Unveils the Protective Function of Ulinastatin against Dextran Sulfate Sodium-Induced Colitis. Antioxidants 2024; 13(2) doi: 10.3390/antiox13020214
|
| 78 |
Yuting Luo, Sai Fu, Yuling Liu, Shasha Kong, Qian Liao, Longfei Lin, Hui Li. Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis. Journal of Ethnopharmacology 2024; 326 doi: 10.1016/j.jep.2024.117990
|
| 79 |
YangLin Cui, YuMeng Guo, YuChen Kong, GuangYe Zhang. Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1348027
|
| 80 |
Daria A. Kuznetsova, Sergey V. Lapin, Irina V. Gubonina. Bile acid dysmetabolism in inflammatory bowel diseases. Almanac of Clinical Medicine 2023; 51(1) doi: 10.18786/2072-0505-2023-51-007
|
| 81 |
Mengfan Li, Lijiao Yang, Chenlu Mu, Yue Sun, Yu Gu, Danfeng Chen, Tianyu Liu, Hailong Cao. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives. Computational and Structural Biotechnology Journal 2022; 20 doi: 10.1016/j.csbj.2022.03.038
|
| 82 |
Rui Zhou, Yangyi Huang, Congjian Tian, Yong Yang, Zaiqi Zhang, Kai He. Coptis chinensis and Berberine Ameliorate Chronic Ulcerative Colitis: An Integrated Microbiome-Metabolomics Study. The American Journal of Chinese Medicine 2023; 51(08) doi: 10.1142/S0192415X23500945
|
| 83 |
Matteo Scanu, Francesca Toto, Valentina Petito, Letizia Masi, Marco Fidaleo, Pierluigi Puca, Valerio Baldelli, Sofia Reddel, Pamela Vernocchi, Giovambattista Pani, Lorenza Putignani, Franco Scaldaferri, Federica Del Chierico. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1366192
|
| 84 |
Johanna Böttcher, Ody C M Sibon, Sahar El Aidy, Hauke Smidt. Coenzyme A metabolism: a key driver of gut microbiota dynamics and metabolic profiles. FEMS Microbiology Reviews 2025; 49 doi: 10.1093/femsre/fuaf051
|
| 85 |
Kushal Roychoudhuri, Saikat Santra, Rajdip Goswami, Bhaskar Pal. Impact of Yoga and Proper Diet on Cardiopulmonary Function. Advances in Medical Diagnosis, Treatment, and Care 2024; doi: 10.4018/979-8-3693-8267-7.ch008
|
| 86 |
Shanxia Yao, Shenglong Xue, Na Li, Tian Shi, Yan Feng, Munila Maimaiti, Ayinuer Maimaitireyimu, Halina Halike, Feng Gao. Integrated analysis of fecal microbiota and metabolomics reveals unique characteristics of asymptomatic and classic celiac disease. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1636007
|
| 87 |
Mengjia Zhao, Bixu Wang, Fangmei Zhou, Chengnan Fang, Bingqi Zhu, Mingyuan Zhou, Xiaoqing Ye, Yuchi Chen, Zhishan Ding. Modeling “Two-Hit” Severe Pneumonia in Mice: Pathological Characteristics and Mechanistic Studies. Inflammation 2024; 48(3) doi: 10.1007/s10753-024-02136-w
|
| 88 |
Yinping Pan, Haojie Zhang, Minghui Li, Tingjing He, Sihao Guo, Liancai Zhu, Jun Tan, Bochu Wang. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2356284
|
| 89 |
Wenying Guan, Xiaotan Jiang, Xiaohua Yu, Xinwei Li, Kangxing Li, Huan Liu, Xinyi Wang, Xixia Liu, Jianjun Hou, Qin Wu, Chunhong Liu. Multi‐Omics Analysis of the Molecular Mechanisms by Which Extract of Artemisia selengensis Turcz. Ameliorates DBP‐Induced Liver Injury. Chemistry & Biodiversity 2025; 22(4) doi: 10.1002/cbdv.202401963
|
| 90 |
Taha H. Alnasrawi, Zahraa A. Althabet, Mustafa Mudhafar, Amani Nadhim Kadhim, Hayder Talib Mahdi, Hasnaa Saeed M.. Survey studies of ulcerative colitis in Iraq. THIRD INTERNATIONAL SCIENTIFIC CONFERENCE: SISC2024 2026; 3415 doi: 10.1063/5.0322239
|
| 91 |
Mei-Na Wang, Chuan-Guo Liu, Jia Pan, Xiao-Gang Pang, Hui-Min Liu. Intestinal Barrier: Mechanisms of Disruption and Strategies for Restoration in Ulcerative Colitis. Gastrointestinal Disorders 2026; 8(2) doi: 10.3390/gidisord8020024
|
| 92 |
Meiling Liu, Siyi Guo, Liang Wang. Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241239580
|
| 93 |
Siyu Li, Kan Xu, Yi Cheng, Lu Chen, Ailin Yi, Zhifeng Xiao, Xuefei Zhao, Minjia Chen, Yuting Tian, Wei Meng, Zongyuan Tang, Shuhong Zhou, Guangcong Ruan, Yanling Wei. The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1188455
|
| 94 |
Wei Niu, Yuelin Dong, Ziwei Fu, Jiajie Lv, Ligui Wang, Zhenhai Zhang, Jiege Huo, Jianming Ju. Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model. International Journal of Biological Macromolecules 2021; 193 doi: 10.1016/j.ijbiomac.2021.11.024
|
| 95 |
Minmin Zhan, Chenxi Zhao, Yanhui Han, Bin Chen, Yilu Chen, Mingyue Song, Yong Cao, Hang Xiao. Citrus-Derived Exosome-like Nanoparticles Attenuate High-Fat Diet-Aggravated Colitis by Gut Microbiota-Metabolites Modulation. Journal of Agricultural and Food Chemistry 2026; 74(6) doi: 10.1021/acs.jafc.5c16340
|
| 96 |
Hongbin Wang, Qiyu Tian, Zhixin Xu, Min Du, Mei-Jun Zhu. Metabolomic profiling for the preventive effects of dietary grape pomace against colorectal cancer. The Journal of Nutritional Biochemistry 2023; 116 doi: 10.1016/j.jnutbio.2023.109308
|
| 97 |
Jingying Zhou, Penghui Lu, Haolong He, Ruhan Zhang, Dican Yang, Qiong Liu, Qianyan Liu, Mi Liu, Guoshan Zhang. The metabolites of gut microbiota: their role in ferroptosis in inflammatory bowel disease. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02524-4
|
| 98 |
Si-Rui Yu, Run Sun, Mei-Ya Shi, Mei Yang, Kun Chen, Qiong Pan, Ling Zhao, Ming-Yue Wu, Jin Chai. The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. Liver Research 2026; 10(1) doi: 10.1016/j.livres.2026.02.001
|
| 99 |
Phurpa Wangchuk, Karma Yeshi, Alex Loukas. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends in Pharmacological Sciences 2024; 45(10) doi: 10.1016/j.tips.2024.08.003
|
| 100 |
Abdulrahman Mujalli, Wesam F. Farrash, Kawthar S. Alghamdi, Ahmad A. Obaid. Metabolite Alterations in Autoimmune Diseases: A Systematic Review of Metabolomics Studies. Metabolites 2023; 13(9) doi: 10.3390/metabo13090987
|
| 101 |
Chi Zhang, Yujia Hu, Yi Yuan, Jingke Guo, Henian Li, Qiaoling Li, Shutao Liu. Liposome-embedded SOD attenuated DSS-induced ulcerative colitis in mice by ameliorating oxidative stress and intestinal barrier dysfunction. Food & Function 2023; 14(9) doi: 10.1039/D2FO03312G
|
| 102 |
Rui Sun, Jingjing Jiang, Ling Yang, Lu Chen, Hong Chen, Walter Fries. Alterations of Serum Bile Acid Profile in Patients with Crohn’s Disease. Gastroenterology Research and Practice 2022; 2022 doi: 10.1155/2022/1680008
|
| 103 |
Tong Liu, Siqing Fan, Pengfei Meng, Mingxia Ma, Yanxin Wang, Jiaojiao Han, Yufei Wu, Xiao Li, Xiurong Su, Chenyang Lu. Dietary Dihydroquercetin Alleviated Colitis via the Short-Chain Fatty Acids/miR-10a-5p/PI3K-Akt Signaling Pathway. Journal of Agricultural and Food Chemistry 2024; 72(42) doi: 10.1021/acs.jafc.4c03278
|
| 104 |
Byron J. Smith, Yvette Piceno, Martin Zydek, Bing Zhang, Lara Aboud Syriani, Jonathan P. Terdiman, Zain Kassam, Averil Ma, Susan V. Lynch, Katherine S. Pollard, Najwa El-Nachef. Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-09307-5
|
| 105 |
Wen-Wen Cheng, Bao-Hong Liu, Xiao-Ting Hou, Huan Meng, Dan Wang, Cheng-Hao Zhang, Shuo Yuan, Qing-Gao Zhang. Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes. The American Journal of Chinese Medicine 2024; 52(05) doi: 10.1142/S0192415X24500514
|
| 106 |
Wenwen Li, Yun Zhang, Quyi Wang, Yu Wang, Yuwen Fan, Erxin Shang, Shu Jiang, Jinao Duan. 6-Gingerol ameliorates ulcerative colitis by inhibiting ferroptosis based on the integrative analysis of plasma metabolomics and network pharmacology. Food & Function 2024; 15(11) doi: 10.1039/D4FO00952E
|
| 107 |
Xingyu Shen, Yue Li, Deqiang Wang, Kang Sun. The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1690279
|
| 108 |
Min Yang, Yu Gu, Lingfeng Li, Tianyu Liu, Xueli Song, Yue Sun, Xiaocang Cao, Bangmao Wang, Kui Jiang, Hailong Cao. Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients 2021; 13(9) doi: 10.3390/nu13093143
|
| 109 |
Serena Onwuka, Laura Bravo-Merodio, Georgios V. Gkoutos, Animesh Acharjee. Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations. iScience 2024; 27(7) doi: 10.1016/j.isci.2024.110298
|
| 110 |
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Piero Portincasa. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Internal and Emergency Medicine 2023; 18(8) doi: 10.1007/s11739-023-03343-3
|
| 111 |
Pawanpreet Singh, Kelly S Swanson, Jennifer Saunders-Blades, Patricia M Oba, E James Squires, Anna K Shoveller. Whole pulse ingredient inclusion in macronutrient-balanced diets increased fecal concentrations of propionic acid but not total bile acids in healthy adult large-breed dogs after 20 weeks. Journal of Animal Science 2025; 103 doi: 10.1093/jas/skaf075
|
| 112 |
Ravi Holani, Haggai Bar-Yoseph, Zakhar Krekhno, Antonio Serapio-Palacios, Kyung-Mee Moon, Richard G. Stacey, Katherine A. Donald, Wanyin Deng, Brian Bressler, Armando A. Magaña, Leonard J. Foster, Michael G. Atser, James D. Johnson, Barton Finlay. Bile acid–induced metabolic changes in the colon promote Enterobacteriaceae expansion and associate with dysbiosis in Crohn’s disease. Science Signaling 2024; 17(867) doi: 10.1126/scisignal.adl1786
|
| 113 |
Wang Haiou, Li Jinyou, Huang Wenkang, Ye Yiping, Gao Lijuan. The regulation of intestinal microbiota and the intervention of Chinese herbal medicine in the treatment of ulcerative colitis. Pharmacological Research - Modern Chinese Medicine 2024; 10 doi: 10.1016/j.prmcm.2024.100356
|
| 114 |
Tingyi Tan, Matthew Vincent, Umang Jain, Parakkal Deepak, Richa Shukla, Themistocles Dassopoulos, Josh Korzenik, Scott Snapper, Satya Kudara, Laura Raffals, Manreet Kaur, Poonam Beniwal-Patel, Ray Cross, David Hudesman, Mazer Ally, Gauree Konijeti, Rebecca Matro, Kirk Russ, Kara De Felice, Joel Pekow, Sushila Dalal, Sheldon Lidofsky, Lauren George, Shrinivas Bishu, Meenakshi Bewtra, James D. Lewis, Richard Duerr, Sumona Saha, Freddy Caldera, Elizabeth Scoville. Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease. Digestive Diseases and Sciences 2026; doi: 10.1007/s10620-026-09779-9
|
| 115 |
Nathan Calzadilla, Shane M. Comiskey, Pradeep K. Dudeja, Seema Saksena, Ravinder K. Gill, Waddah A. Alrefai. Bile acids as inflammatory mediators and modulators of intestinal permeability. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1021924
|
| 116 |
Hao Cheng, Dandan Zhang, Jing Wu, Juan Liu, Yuzhu Tan, Wuwen Feng, Cheng Peng. Atractylodes macrocephala Koidz. volatile oil relieves acute ulcerative colitis via regulating gut microbiota and gut microbiota metabolism. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1127785
|
| 117 |
Yulia Shulpekova, Maria Zharkova, Pyotr Tkachenko, Igor Tikhonov, Alexander Stepanov, Alexandra Synitsyna, Alexander Izotov, Tatyana Butkova, Nadezhda Shulpekova, Natalia Lapina, Vladimir Nechaev, Svetlana Kardasheva, Alexey Okhlobystin, Vladimir Ivashkin. The Role of Bile Acids in the Human Body and in the Development of Diseases. Molecules 2022; 27(11) doi: 10.3390/molecules27113401
|
| 118 |
Zheng Li, Tianjiao Chu, Xin Sun, Shen Zhuang, Dianbo Hou, Zhaohan Zhang, Jialu Sun, Yuhong Liu, Jing Li, Yifei Bian. Polyphenols-rich Portulaca oleracea L. (purslane) alleviates ulcerative colitis through restiring the intestinal barrier, gut microbiota and metabolites. Food Chemistry 2025; 468 doi: 10.1016/j.foodchem.2024.142391
|
| 119 |
Yanmin He, Weike Shaoyong, Yanli Chen, Menglin Li, Yujie Gan, Lu Sun, Yalin Liu, Yizhen Wang, Mingliang Jin. The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity. Journal of Advanced Research 2026; 80 doi: 10.1016/j.jare.2025.05.015
|
| 120 |
Xingqiang Huang, Xueyi Chen, Guowei Wan, Dandan Yang, Dongqiang Zhu, Linqian Jia, Jinping Zheng. Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma——based on microbiomics and metabolomics. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11982-8
|
| 121 |
Sho Kitamoto, Nobuhiko Kamada. Untangling the oral–gut axis in the pathogenesis of intestinal inflammation. International Immunology 2022; 34(9) doi: 10.1093/intimm/dxac027
|
| 122 |
Xianhong Zhang, Rongqing Li, Yue Gao, Wenjia Zhang, Ting Ni, Yongbin Liu. The gut as a central hub for multi-organ crosstalk in aging. Cellular and Molecular Life Sciences 2026; 83(1) doi: 10.1007/s00018-026-06129-w
|
| 123 |
Jeanne A. Ishimwe, Thanvi Dola, Lale A. Ertuglu, Annet Kirabo. Bile acids and salt-sensitive hypertension: a role of the gut-liver axis. American Journal of Physiology-Heart and Circulatory Physiology 2022; 322(4) doi: 10.1152/ajpheart.00027.2022
|
| 124 |
Feng Xu, Hongmei Wu, Xiangpei Wang. Exploring the role and mechanism of herbal pair fanbaicao-daxueteng in the treatment of UC based on GEO chip and bioinformatics. Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science 2023; doi: 10.1145/3644116.3644313
|
| 125 |
Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin. Nigakinone alleviates DSS‐induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathways. Phytotherapy Research 2023; 37(1) doi: 10.1002/ptr.7588
|
| 126 |
Juan Hernandez, Soufien Rhimi, Aicha Kriaa, Vincent Mariaule, Houda Boudaya, Amandine Drut, Amin Jablaoui, Héla Mkaouar, Amel Saidi, Vincent Biourge, Mohamed Ali Borgi, Moez Rhimi, Emmanuelle Maguin. Domestic Environment and Gut Microbiota: Lessons from Pet Dogs. Microorganisms 2022; 10(5) doi: 10.3390/microorganisms10050949
|